Dr. Fei Deng will discuss recent developments in standard essential patent (SEP) litigations and FRAND royalty rate determination in China.
To register, click here.
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Dr. Fei Deng will discuss recent developments in standard essential patent (SEP) litigations and FRAND royalty rate determination in China.
To register, click here.
The issue is especially timely given provisions in the EU’s Digital Markets Act (DMA) designed to expand access to data held by large digital platforms. The...
We are pleased to present the latest edition of CRA’s IP Literature Watch. This issue contains pieces on antitrust & IP, licensing, litigation, innovation, law...
CRA is a proud sponsor of the conference focusing on the theme of “Competition and Foreign Investment Law for a Resilient Canada.” At a pivotal moment for...
CRA is a proud sponsor of the event. Josh Sherman is a panelist during the session titled “Global antitrust trends reshaping the life sciences market”...
